Abstract
In this paper, we describe the physical map and transcriptional organisation of a 100-kb region with the BRCA1 locus at 17q12–21. Using the cDNA of the EDH17B2 gene as a probe, we screened a human genomic cosmid library. Positive cosmid clones were aligned and a contig around the EDH17B2 gene was established, expanding the previously reported map. In order to identify genes located in this region, we used the cosmid inserts to select cDNAs from a human ovarian cDNA library. Among the clones identified, cDNA OV-1 corresponds to a human homologue of a rat PRL-1 tyrosine phosphatase gene that shows enhanced expression during hepatic regeneration and in some tumour cell lines. Neither the OV-1 nor the PRL-1 protein shares strong homology with any previously characterised phosphotyrosine phosphatase, suggesting that they probably belong to a new phosphatase family. In an attempt to characterise the OV-1 gene, we found that the genomic sequence present on chromosome 17 probably corresponds to a nonfunctional copy of the gene, as it contains several sequence changes that disrupt the potential coding information of the gene. Three other cDNAs, corresponding to unrelated genes, were also identified and characterised. They did not reveal striking homologies in database sequence comparison and therefore represent new genes localised on chromosome 17q, in a region that frequently shows loss of heterozigosity in sporadic breast and ovarian cancers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albertsen HM, Smith SA, Mazoyer S, Fujimoto E, Stevens J, Williams B, Rodriguez P, Cropp CS, Slijepcevic P, Carlson MM, Robertson M, Bradley P, Lawrence E, Harrington T, MeiSheng Z, Hoopes R, Sternberg N, Brothman A, Callahan R, Ponder BAJ, White R (1994) A physical map and candidate genes in BRCA1 region on chromosome 17q12–21. Nature Genet 7:472–479
Anderson LA, Friedman L, Osborne-Lawrence S, Lynch E, Weissenbach J, Bowcock A, King MC (1993) High-density genetic map of the BRCA1 region of chromosome 17q12–q21. Genomics 17:618–623
Bowcock AM, Anderson LA, Friedman LS, Black DM, Osborne-Lawrence S, Rowell SE, Hall JM, Solomon I, King MC (1993) THRA1 and D17S183 flank an interval < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet 52:718–722
Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC, Solomon E, Trowsdale J, Black DM (1994) A novel gene encoding a B-box protein within the BRCA1 gene at 17q21.1. Hum Mol Genet 3:589–594
Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS, Weber BL (1994) Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8:387–391
Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232–242
Cornelis RS, Devilee P, Vliet M van, Kuipers-Dijkshoorn N, Kersenmaeker A, Bardoel A, Khan PM, Cornelisse CJ (1993) Allele loss patterns on chromosome 17q in 109 breast carcinomas indicate at least two distinct target regions. Oncogene 8:781–785
Cropp CS, Champeme MH, Lidereau R, Callahan R (1993) Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53:5617–5619
Diamond RH, Cressman DE, Laz TM, Abrams CS, Taub R (1994) PRL-1, a unique nuclear protein tyrosine phosphatase affects cell growth. Mol Cell Biol 14:3752–3762
Easton DF, Bishop DT, Ford D, Crockford GP, The Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678–701
Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowel SE, King MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet 8:399–404
Futreal PA, Cochran C, Rosenthal J, Miki Y, Swenson J, Hobbs M, Bennett LM, Haugen-Strano A, Marks J, Barrett JC, Tavtigian SV, Shattuck-Eidens D, Kamb A, Skolnick M, Wiseman RW (1994a) Isolation of a diverged homoeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture. Hum Mol Genet 3:1359–1364
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R (1994b). BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120–122
Hall JM, Lee MK, Newman B, Morrow J, Anderson L, Huey B, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689
Jones KA, Black DM, Brown MA, Griffiths BL, Nicolai HM, Chambers JA, Bonjardim M, Xu CF, Boyd M, McFarlane R, Korn B, Poustka A, North MA, Schalkwyk L, Lehrach H, Solomon E (1994) The detailed characterisation of a 400 kb cosmid walk in the BRCA1 region: identification and localisation of 10 genes including a dual-specificity phosphatase. Hum Mol Genet 3:1927–1934
Kamb A, Futreal PA, Rosenthal J, Cochran C, Harshman KD, Liu Q, Phelps RS, Tavigian SV, Tran T, Hussey C, Bell R, Miki Y, Swensen J, Hobbs M, Marks J, Bennett L, Barrett JC, Wiseman RW, Shattuck-Eidens D (1994) Localization of the VHR phosphatase gene and its analysis as a candidate for BRCA1. Genomics 23: 163–167
Kelsell DP, Black DM, Bishop DT, Spurr NK (1993) Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet 2: 1823–1828
Knudson AG (1985) Hereditery cancer, oncogenes and antioncogenes. Cancer Res 45:1437–1443
Kozak M (1987) An analysis of 5′-noncoding sequences from 699 vertebrate mesenger RNAs. Nucleic Acids Res 15:8125–8148
Luu-The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Béruhé G, Gagné R, Labrie F (1989) Characterization of cDNAs for human estradiol 17-β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′ termini in human placenta. Mol Endocrinol 3: 1301–1309
Luu-The V, Labrie C, Simard J, Lachance Y, Zhao H-F, Couët J, Leblanc G, Labrie F (1990) Structure of two in tandem human β-hydroxysteroid dehydroeenase genes. Mol Endocrinol 4:268–275
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bodgen R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71
Mohn KL, Laz TM, Hsu J-C, Melby AE, Bravo R, Taub R (1991) The immediate-early growth response in regenerating liver and insulin-stimulated H35 cells: comparison with serum stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol 11:381–390
Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM (1991) Familial breast-ovarian cancer locus on chromosome 17q12–q23. Lancet 338:82–83
Neuhausen SL, Swensen J, Miki Y, Liu Q, Tavtigian S, Shattuck-Eidens D, Kamb A, Hobbs MR, Gingrich J, Shizuya H, Kim UJ, Cochran C, Futreal PA, Wiseman RW, Lynch HT, Tonin P, Narod S, Cannon-Albright L, Skolnick MH, Goldgar DE (1994) A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. Hum Mol Genet 3: 1919–1926
Russel SEH, Hickey GI, Lowry WS, White P, Atkinson RJ (1990) Allele loss from chromosome 17 in ovarian cancer. Oncogene 5:1581–1583
Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y (1993) Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53:3382–3385
Simard J, Feunteun J, Lenoir MG, Tonin P, Normand T, Luu-The V, Vivier A, Lasko D, Morgan K, Rouleau G, Lynch H, Labric F, Narod S (1993) Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12–21; exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet 2: 1193–1199
Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, Belanger C, Dion F, Liu Q, Skolnick M, Goldgar D, Shattuck-Eidens D, Labrie F, Narod S (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8:392–398
Smith SA, Easton DF, Evans DGR, Ponder BAJ (1992) Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 2:128–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Montagna, M., Serova, O., Sylla, B.S. et al. A 100-kb physical and transcriptional map around the EDH17B2 gene: identification of three novel genes and a pseudogene of a human homologue of the rat PRL-1 tyrosine phosphatase. Hum Genet 96, 532–538 (1995). https://doi.org/10.1007/BF00197407
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00197407